Elphogene

About:

Elphogene is a biotechnological company providing tools and services for liquid-biopsy testing in cancer.

Website: https://www.elphogene.cz

Twitter/X: elphogene

Top Investors: i&i Prague

Description:

Elphogene provides a molecular oncomonitor for the detection of cancer progression and treatment monitoring. It is a diagnostic tool based on liquid biopsy screening of ctDNA in the peripheral blood of cancer patients. It is to follow-up with patients in advanced stages of cancer for early detection of newly arising metastatic lesions.

Total Funding Amount:

$500000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Prague, Hlavni mesto Praha, Czech Republic

Founded Date:

2018-12-01

Founders:

Lucie Benesova, Marek Minarik

Number of Employees:

1-10

Last Funding Date:

2020-04-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai